Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-20

Clinical Trial Update: The Effects of CGMP in Children and Adults With PKU [NA]

View source ↗

Summary

This Clinical Trial Update reports on a completed study of CGMP in children and adults with phenylketonuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CGMP (casein glycomacropeptide) (casein glycomacropeptide)

Snippet

Sponsor: Vitaflo International, Ltd | Conditions: Phenylketonurias | NA | Status: COMPLETED